This is all the other psychedelic research that came out in September 2020. These papers don’t (yet) have their own page in our database.

Find our recap of the most interesting papers this month in our September Recap.

You can find all interesting papers in our Papers Database.

Related papers

Use CTRL/CMD+F to quickly search if anything relevant for you has been published this month.

• The Ayahuasca Experience: A Phenomenological Study of Tourists in Iquitos, Peru (master thesis, field work study)
• Psychiatric Medications and Hypertension (esketamine and hypertension review, no contraindications found)
• Ketamine, but not guanosine, as a prophylactic agent against corticosterone-induced depressive-like behavior: Possible role of long-lasting pro-synaptogenic signaling pathway (in mice)
• Ketamine potentiates TRPV1 receptor signaling in the peripheral nociceptive pathways (in rats)
• NICE reconsiders esketamine for depression (second rejection of esketamine, because too costly, by NICE (UK))
• Intranasal delivery of rapid-onset antidepressants: a new trend of treating major depressive disorder (review of ketamine and delivery pathways)
• GABAB receptor intracellular signaling: novel pathways for depressive disorder treatment? (impact of ketamine on GABAergic synaptic transmission)
• Marginalization, stigma and abandonment of LSD in medicine (French, history of LSD use/abandonment in psychotherapy)
• Psychotherapy assisted by psychedelics, intense and unusual exposures therapy (French, overview of how and why psychedelic-assisted psychotherapy works)
• Re-evaluation of the discriminative stimulus effects of lysergic acid diethylamide with male and female Sprague-Dawley rats (studying sex differences, in mice, uhh rats)
• Efficacy of Psychoactive Drugs for the Treatment of Posttraumatic Stress Disorder: A Systematic Review of MDMA, Ketamine, LSD and Psilocybin (more review articles, this one is more critical and ranking ketamine(-assisted psychotherapy) as very low, MDMA as moderate, based on nine included trials)
• Psychedelic Telepathy: An Interview Study (interviews with people explaining their telepathic abilities on psychedelics, not my area of interest/expertise)
• Meetings with Mother Ayahuasca: The effects of the spiritual experience on mental processes and physiological responses (thesis)
• Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders (review, by Vollenweider & Preller)
• Classic Psychedelics as a Psychotherapeutic Aid in the Treatment of Stimulant Use Disorder: a Case Report (positive case report on how someone used psychedelics (outside/next to therapy) to stop using stimulant drugs)
• Culture and psychedelic psychotherapy: Ethnic and racial themes from three Black women therapists (good discussion and experiences on cultural issues and blindspots for expanding psychedelic-assisted psychotherapy)
• Total Recall: Lateral Habenula and Psychedelics in the Study of Depression and Comorbid Brain Disorders (neuroscience perspective on psychedelics and depression)
• Phytochemical, Cytotoxicity, Antioxidant and Anti-Inflammatory Effects of Psilocybe Natalensis Magic Mushroom (magic mushrooms are anti-inflammatory, a sub-field that will yield very interesting results over the coming years)
• Immunochemical monitoring of psilocybin and psilocin to identify hallucinogenic mushrooms (making it easier for anyone? to find which mushrooms contain psilocybin and psilocin)
• Development of an improved psilocybin synthesis (thesis)
• Dr. Valentina Wasson: Questioning what we think we know about the foundations of psychedelic science (critique on equity, access, and history of psychedelic science)
• Chemical Composition of Traditional and Analog Ayahuasca (information about the composition of different ‘strains’ of ayahuasca)
• Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy (the safety of MDMA (physiological and mental) may not be perfect, this review article offers suggestions for alternative (classes of) drugs)
• Identification of psychedelic new psychoactive substances (NPS) showing biased agonism at the 5-HT _2A R through simultaneous use of β-arrestin 2 and miniGα _q bioassays (investigating why/how novel psychedelics work)
• The Antidepressant Effect of Ketamine Is Dampened by Concomitant Benzodiazepine Medication (ketamine x benzodiazepine)
• What is the drug of choice of young festivalgoers? (MDMA is the most popular)
• N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo (in mice)
• The Importance of Ritual Discourse in Framing Ayahuasca Experiences in the Context of Shamanic Tourism (looking at the ritual, especially the shaman’s speeches)
• Tropane-Based Ibogaine Analog Rescues Folding-Deficient Serotonin and Dopamine Transporters (in cells and flies)
• Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis (meta-analysis that favors racemic – intravenous ketamine over esketamine)